USPTO serial 79182078
CODAN
Reviewed by CopyMark Law Group
Reg. 5197701Status 739Renewal
- Filing date
- Status date
- Registration date
- May 9, 2017
- Examiner
- CORWIN, KEVIN SCOTT
- Law office
- GENERIC WEB UPDATE
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CODAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joseph A. Sebolt
Joseph A. Sebolt SAND, SEBOLT & WERNOW CO., LPA4940 Munson Street, NWAegis Tower, Suite 1100Canton, OH 44718Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical apparatus and instruments for infusion, transfusion, drawing blood, measuring blood pressure, providing enteral and oral nutrition, and for surgical procedures in the fields of urology, incontinence, neonatology and pediatrics; Medical apparatus and instruments, namely, infusion sets, transfusion sets, extension tube lines and manifold connectors for the delivery of fluids for medical purposes, intravenous (I.V.) filters and filter systems comprised of particular matter traps to isolate foreign matter while allowing infusion fluids to pass into a patient's system, catheters, medical valves for controlling the flow of fluids through infusion tubing, infusion spikes in the nature of specialized needles for intravenous infusion, infusion lines in the nature of tubing for the delivery of intravenous and orally administered fluids, drip chambers to allow gas to rise out of intravenous fluids so that it is not passed downstream, special sets for preparation and administration of total intravenous anesthesia (TIVA) with said sets being comprised primarily of syringes sold empty, syringe pumps, medical valves for controlling the flow of fluids through infusion tubes, infusion lines and manifold connections for the delivery of fluids for medical purposes, drip chambers to allow gas to rise out of intravenous fluids so that it is not passed downstream, infusion spikes in the nature of specialized needles for intravenous infusion, intravenous (I.V.) filters and/or filter systems comprised of particular matter traps to isolate foreign matter while allowing infusion fluids to pass into a patient's system, special sets for preparation and administration of cytotoxic drugs, with said sets being comprised primarily of extension tube lines and manifold connectors for the delivery of fluids for medical purposes, intravenous (I.V.) filters and filter systems comprised of particular matter traps to isolate foreign matter while allowing infusion fluids to pass into a patient's system, medical valves for controlling the flow of fluids through infusion tubes, infusion spikes in the nature of specialized needles for intravenous infusion, infusion lines in the nature of tubing for the delivery of intravenous and orally administered fluids, drip chambers to allow gas to rise out of intravenous fluids so that it is not passed downstream, cannulas, syringes sold empty, protective clothing for medical purposes, namely, coveralls, gowns, hoods, face masks, filter masks, gloves, safety glasses, overshoes for protection against accidents with cytotoxic drugs, bags and containers for disposing of contaminated cleaning materials and spilled hazardous drugs, workplace covers used on table and counter surfaces to absorb spills during the preparation of cytotoxic drugs, medical tubing extensions for enteral and oral nutrition, disposable syringes sold empty, invasive blood pressure monitoring systems, urology administration and irrigation sets, infusion pumps, syringe pumps, withdrawal sets for withdrawal of blood comprised primarily of burettes, extension tube lines and manifold connectors for the delivery of fluids for medical purposes, intravenous (I.V.) filters and filter systems comprised of particular matter traps to isolate foreign matter while allowing infusion fluids to pass into a patient's system, medical valves for controlling the flow of fluids through infusion tubing, infusion spikes in the nature of specialized needles for intravenous infusion, infusion lines in the nature of tubing for the delivery of intravenous fluids, drip chambers to allow gas to rise out of intravenous fluids so that it is not passed downstream, medical tubing for the withdrawal of blood, syringes sold empty, cannulas, preparation sets for preparation of drugs comprised primarily of extension lines and manifold connectors for the delivery of fluids for medical purposes, intravenous (I.V.) filters and filter systems comprised of particular matter traps to isolate foreign matter while allowing infusion fluids to pass into a patient's system, medical valves for controlling the flow of fluids through infusion tubing, infusion spikes in the nature of specialized needles of intravenous infusion, infusion lines in the nature of tubing for the delivery of intravenous and orally administered fluid, drip chambers to allow gas to rise out of intravenous fluids so that it is not passed downstream, cannulas, syringes sold empty, protective gloves for medical purposes, protective gowns for medical purposes, bags and containers for disposing of contaminated cleaning materials and spilled hazardous drugs, workplace covers used on table and counter surfaces to absorb spills during the preparation of drugs, administration sets for administration of drugs and liquids, with said sets being comprised primarily of burettes, extension lines and manifold connectors for the delivery of fluid for medical purposes, intravenous (I.V.) filters and filter systems comprised of particular matter traps to isolate foreign matter while allowing infusion fluids to pass into a patient's system, medical valves for controlling the flow of fluids through infusion tubing, infusion spikes in the nature of specialized needles for intravenous infusion, infusion lines in the nature of tubing for the delivery of intravenous and orally administered fluids, drip chambers to allow gas to rise out of intravenous fluids so that it is not passed downstream, medical tubing for the withdrawal of blood, syringes sold empty, and cannulas, workplace covers used on table and counter surfaces to absorb spills during the preparation of drugs, spill sets for safe removal of hazardous drugs comprised primarily of barriers to restrict access to contaminated areas, caution tape, containers for disposing of contaminated cleaning materials and spilled hazardous drugs, cleaning material for removing hazardous drugs, protective clothing for medical purposes, namely coveralls, gowns, hoods, face masks, filter masks, gloves, safety glasses, overshoes for protection against accidents with hazardous drugs, bags and containers for contaminated items, cleaning material, spilled hazardous drugs, and workplace covers for covering medical workplaces for protection against accidents with hazardous drugs; parts and fittings of all the aforesaid goods; protective clothing for medical purposes, namely, coveralls, gowns, hoods, face masks, filter masks, gloves, safety glasses, overshoes for protection against accidents with cytotoxic drugs | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 9, 2026 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Dec 18, 2025 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jan 9, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 4, 2024 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Jan 4, 2024 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Jan 4, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 13, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 8, 2023 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| May 9, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 20, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 20, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 22, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 11, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 11, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 9, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 27, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 9, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 16, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 21, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 21, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 1, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 1, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 1, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 23, 2017 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Jan 9, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 29, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 29, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 29, 2016 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 25, 2016 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Nov 4, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 18, 2016 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 17, 2016 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 21, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 21, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 21, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 13, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 23, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 23, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 23, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 22, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 20, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 16, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 12, 2016 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Feb 11, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |